Severe Sepsis/Septic Shock on Admission to the General Surgical ICU

Launched by MAHIDOL UNIVERSITY · May 28, 2011

Keywords

ClinConnect Summary

This clinical trial is studying severe sepsis and septic shock in adult surgical patients who are admitted to the general surgical intensive care unit (ICU). Severe sepsis and septic shock are serious infections that can lead to multiple organ failure and can be life-threatening. The researchers want to understand how quickly and effectively treating these conditions can improve survival rates and outcomes for patients. They will be looking at factors such as the type and amount of fluids given in the first few days after diagnosis and how these treatments affect recovery, ICU stay length, and overall mortality rates.

To be eligible for this study, participants must be adults (over 18 years old) who have had surgery and are admitted to the general surgical ICU. They must also agree to take part in the study. However, patients who are undergoing heart, brain, or trauma surgeries, or who do not give consent, cannot participate. If you or a loved one qualify for this study, you will be part of a group of 800 patients, and researchers will monitor your health closely to gather important information that could improve treatment for future patients facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult (\> 18 years) surgical patient admitting to the general surgical ICU
• • Consent to this study
• Exclusion Criteria:
• • Patient undergoing cardiothoracic surgery, neurosurgery and traumatic surgery
• • Not consent to this study